Other Titles

Nurse-managed technology to enhance cancer care outcomes for survivors with breast cancer or head/neck cancer [Symposium]

Abstract

We will describe development and testing of the 3D mobile device for application in clinical and home use for assessment, early detection, and self-management of lymphedema in those at risk following breast cancer treatment.

Author Details

Jane Armer, PhD - Sinclair School of Nursing and Ellis Fischel Cancer Center, University of Missouri, Columbia, Missouri, USA; Nathan C. Armer, MEd - Sinclair School of Nursing, University of Missouri, Columbia, Missouri, USA; Guilherme N. DeSouza, PhD - Department of Electrical and Computer Engineering and MU Informatics Institute, University of Missouri, Columbia, Missouri, USA

Sigma Membership

Alpha Iota

Lead Author Affiliation

University of Missouri, Columbia, Missouri, USA

Type

Presentation

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Lymphedema, Mobile Device Technology, Prospective Surveillance

Conference Name

28th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Dublin, Ireland

Conference Year

2017

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (263 kB)

Share

COinS
 

Mobile platform for assessment, early detection, and management of breast cancer-related lymphedema

Dublin, Ireland

We will describe development and testing of the 3D mobile device for application in clinical and home use for assessment, early detection, and self-management of lymphedema in those at risk following breast cancer treatment.